Published in Neurology on January 01, 1985
Length of survival of patients with acquired immune deficiency syndrome in the United Kingdom. Br Med J (Clin Res Ed) (1986) 1.37
Restless legs syndrome. Br Med J (Clin Res Ed) (1987) 1.29
Hypersomnia. Dialogues Clin Neurosci (2005) 0.82
Genetics of narcolepsy and other sleep disorders. Am J Hum Genet (1997) 0.81
Restless legs syndrome and nocturnal myoclonus: initial clinical manifestation of familial amyloid polyneuropathy. J Neurol Neurosurg Psychiatry (1990) 0.78
Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome. J Neurol (2017) 0.78
Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature (1983) 11.57
Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line. Science (1995) 4.19
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology (2008) 3.62
Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology (1992) 3.08
Multiple regulatory elements in the intergenic region between the alpha-fetoprotein and albumin genes. Mol Cell Biol (1986) 2.83
Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A (1997) 2.50
REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology (2002) 2.44
REM sleep behaviour disorder in Parkinson's disease is associated with specific motor features. J Neurol Neurosurg Psychiatry (2008) 2.22
Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology (2007) 2.15
The effects of pramipexole in REM sleep behavior disorder. Neurology (2003) 2.10
Tryptophan depletion causes a rapid lowering of mood in normal males. Psychopharmacology (Berl) (1985) 2.02
Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology (2001) 1.95
REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology (2007) 1.95
CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res (1994) 1.76
Tissue-specific transcription of the mouse alpha-fetoprotein gene promoter is dependent on HNF-1. Mol Cell Biol (1989) 1.74
Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma. Nature (1983) 1.71
Dynamics of slow-wave activity during the NREM sleep of sleepwalkers and control subjects. Sleep (2000) 1.66
EEG and cardiac activation during periodic leg movements in sleep: support for a hierarchy of arousal responses. Neurology (1999) 1.62
Development of sleep patterns in early adolescence. J Sleep Res (2001) 1.61
Persistent neuropsychological deficits and vigilance impairment in sleep apnea syndrome after treatment with continuous positive airways pressure (CPAP). J Clin Exp Neuropsychol (1993) 1.59
Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits. J Clin Exp Neuropsychol (1991) 1.57
Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis. Neurology (2001) 1.54
Slow-wave activity in sleep apnea patients before and after continuous positive airway pressure treatment: contribution to daytime sleepiness. Chest (2001) 1.49
Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology (1987) 1.45
The effects of L-dopa on excessive daytime sleepiness in narcolepsy. Neurology (1991) 1.41
Nocturnal asthma: features of attacks, sleep and breathing patterns. Am Rev Respir Dis (1982) 1.41
Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J Biol Chem (2000) 1.38
Age-related modifications of NREM sleep EEG: from childhood to middle age. J Sleep Res (2001) 1.37
Cognitive deficits associated with sleep apnea syndrome: a proposed neuropsychological test battery. Sleep (2000) 1.37
Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology (2008) 1.35
Sleep spindle characteristics in healthy subjects of different age groups. Clin Neurophysiol (2001) 1.34
Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet (2001) 1.30
Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies. Brain Res (1974) 1.29
Development of parasomnias from childhood to early adolescence. Pediatrics (2000) 1.29
Velocity characteristics of normal human saccades. Invest Ophthalmol (1974) 1.26
Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature (1979) 1.26
Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone: roles of tryptophan catabolism and kynurenine synthesis. Br J Pharmacol (1981) 1.25
Mood-lowering effect of tryptophan depletion. Enhanced susceptibility in young men at genetic risk for major affective disorders. Arch Gen Psychiatry (1994) 1.24
Neurobiology of sleep disturbances in neurodegenerative disorders. Curr Pharm Des (2008) 1.24
Behavioral disinhibition induced by tryptophan depletion in nonalcoholic young men with multigenerational family histories of paternal alcoholism. Am J Psychiatry (1999) 1.24
Respiration-dependent uptake of dihydrostreptomycin by Escherichia coli. Its irreversible nature and lack of evidence for a uniport process. Biochem J (1985) 1.23
"Sucrose analgesia" and diphtheria-tetanus-pertussis immunizations at 2 and 4 months. J Dev Behav Pediatr (1995) 1.21
Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation. Neurology (2002) 1.20
Effect of 5-hydroxytryptamine precursors on morphine analgesia in the formalin test. Pharmacol Biochem Behav (1988) 1.19
Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry (1980) 1.16
The effect of tryptophan on social interaction in everyday life: a placebo-controlled study. Neuropsychopharmacology (2001) 1.15
Stress and depressed mood in medical students, law students, and graduate students at McGill University. Acad Med (1997) 1.13
Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Oncogene (1995) 1.12
The response of crying newborns to sucrose: is it a "sweetness" effect? Physiol Behav (1999) 1.10
Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and GABAergic components. Neuroscience (1992) 1.09
Tryptophan depletion, executive functions, and disinhibition in aggressive, adolescent males. Neuropsychopharmacology (1998) 1.09
Clinical prediction of Parkinson's disease: planning for the age of neuroprotection. J Neurol Neurosurg Psychiatry (2010) 1.08
Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacology (1996) 1.07
The cold pressor test in children: methodological aspects and the analgesic effect of intraoral sucrose. Pain (1994) 1.07
Effects of intra-oral sucrose on crying, mouthing and hand-mouth contact in newborn and six-week-old infants. Dev Med Child Neurol (1994) 1.07
Brain Regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry (2001) 1.06
Second report on chicken genes and chromosomes 2005. Cytogenet Genome Res (2005) 1.05
Antidepressant action of tryptophan. Lancet (1974) 1.05
Association of human DEAD box protein DDX1 with a cleavage stimulation factor involved in 3'-end processing of pre-MRNA. Mol Biol Cell (2001) 1.05
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med (1980) 1.05
Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: verification by standard staining techniques, new densitometric methods, and somatic cell hybridization. Hum Genet (1984) 1.04
The ontogeny of alpha-fetoprotein gene expression in the mouse gastrointestinal tract. J Cell Biol (1990) 1.04
Cigarette smoking as a risk factor or an exacerbating factor for restless legs syndrome and sleep bruxism. Sleep (1997) 1.04
Myoclonus in familial restless legs syndrome. Arch Neurol (1976) 1.04
Study of the brain serotonergic system with labeled alpha-methyl-L-tryptophan. J Neurochem (2001) 1.04
Effect of tryptophan administration on tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry (1981) 1.03
Periodic arm movements in patients with the restless legs syndrome. Eur Neurol (2000) 1.03
Restless legs syndrome and periodic movements in sleep: physiopathology and treatment with L-dopa. Clin Neuropharmacol (1986) 1.03
Electromyographic studies of congenital mirror movements. Neurology (1986) 1.03
Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma. Neoplasia (1999) 1.02
Arm restlessness in patients with restless legs syndrome. Mov Disord (2000) 1.01
Topographical distribution of spindles and K-complexes in normal subjects. Sleep (1997) 1.01
Voluntary consumption of beverage alcohol by vervet monkeys: population screening, descriptive behavior and biochemical measures. Pharmacol Biochem Behav (1990) 1.01
The effect of gamma-hydroxybutyrate on nocturnal and diurnal sleep of normal subjects: further considerations on REM sleep-triggering mechanisms. Sleep (1990) 1.01
Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism. Eur Neurol (1991) 1.01
The effect of local cooling upon spontaneous and evoked electrical activity of cerebral cortex. Can J Physiol Pharmacol (1970) 1.00
Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology (2004) 1.00
Regulation of brain fatty acid-binding protein expression by differential phosphorylation of nuclear factor I in malignant glioma cell lines. J Biol Chem (2000) 1.00
Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit. Crit Care Med (1992) 0.99
Effects on mood of acute phenylalanine/tyrosine depletion in healthy women. Neuropsychopharmacology (2000) 0.99
Nocturnal hypoxemia as a determinant of vigilance impairment in sleep apnea syndrome. Chest (1991) 0.99
Cortical trapping of alpha-[(11)C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage (2006) 0.99
Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology (1988) 0.98
Tryptophan catabolism by tryptophan pyrrolase in rat liver. The effect of tryptophan loads and changes in tryptophan pyrrolase activity. J Biol Chem (1975) 0.98
Development of disturbing dreams during adolescence and their relation to anxiety symptoms. Sleep (2000) 0.98
The origin of indoleacetic acid and indolepropionic acid in rat and human cerebrospinal fluid. J Neurochem (1980) 0.97
An amino acid mixture deficient in phenylalanine and tyrosine reduces cerebrospinal fluid catecholamine metabolites and alcohol consumption in vervet monkeys. Psychopharmacology (Berl) (1998) 0.97
Liver and brain tryptophan metabolism following hydrocortisone administration to rats and gerbils. Br J Pharmacol (1975) 0.97
Effects of obstructive sleep apnea on cognitive function: a comparison between younger and older OSAS patients. Sleep Med (2007) 0.97
Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology (2006) 0.97
Differential expression of AP-2alpha and AP-2beta in the developing chick retina: repression of R-FABP promoter activity by AP-2. Dev Dyn (1999) 0.96
Altered dopamine transporter densities in alcohol-preferring vervet monkeys. Neuroreport (1996) 0.96
Importance of tryptophan pyrrolase and aromatic amino acid decarboxylase in the catabolism of tryptophan. Biochem Pharmacol (1978) 0.96
Daytime sleepiness and EEG spectral analysis in apneic patients before and after treatment with continuous positive airway pressure. Chest (2001) 0.95
HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence. Sleep (1986) 0.95
Age difference in heart rate changes associated with micro-arousals in humans. Clin Neurophysiol (2002) 0.95
The metabolism of a tryptophan load in rat brain and liver. The influence of hydrocortisone and allopurinol. Biochem Pharmacol (1976) 0.95
Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Ann Neurol (1982) 0.95